rights allegedly violated and the acts allegedly violative of such rights are identical,
regardless of whether the patents on which the complaints were based are different. In
both cases, the ultimate objective of Pfizer was to ask for damages and to permanently
prevent Pharmawealth from selling the contested products. Relevantly, the Supreme
Court has decided that the filing of two actions with the same objective, as in this
instance, constitutes forum shopping.
Owing to the substantial identity of parties, reliefs and issues in the IPO and RTC cases,
a decision in one case will necessarily amount to res judicata in the other action.